| amisulpride / Generic mfg. |
| Recruiting | 4 | 40 | | | Bristol Meyers Squibb Pharmaceuticals, Bristol Meyers Squibb Pharmaceuticals | Schizophrenic and schizoaffective disorder | | | | |
ChiCTR2000036891: SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia |
|
|
| Not yet recruiting | 4 | 156 | | Clozapine 400 ~ 600mg/d or plasma concentration >350ng/ml Amisulpride 200-800mg/d Gingke biloba 120-360mg/d ;Clozapine 400 ~ 600mg/d or plasma concentration >350ng/ml Amisulpride 200-800mg/d | Shanghai Mental Health Mental; Shanghai Mental Health Mental, Shanghai Shenkang three year action plan | Schizophrenia | | | | |
2009-010547-13: Amisulpride versus Placebo in Functional Dyspespia with delayed gastric emptying |
|
|
| Ongoing | 4 | 60 | Europe | Amisulpride EG, Amisulpride EG | UZLeuven | delayed gastric emptying | | | | |
2017-002406-12: HAMLETT. Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A study comparing continuation versus discontinuation/dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis HAMLETT. Handling Antipsychotic Medication: Lange termijn evaluatie van specifiek toegepaste medicatie. Vergelijking tussen het doorgaan met antipsychotische medicatie bij patiënten die hersteld zijn van eerste psychotische episode en vroegtijdig afbouwen/stoppen. |
|
|
| Not yet recruiting | 4 | 512 | Europe | RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE, CID5073, CID135398745, CID5002, CID60795, CID3559, CID5355, CID115237, CID16362, CID213046, CID135398737, CID2159, CID5467, CID60149, CID667467, CIS5311507, Tablet, RISPERIDONE, OLANZAPINE, QUETIAPINE, ARIPIPRAZOLE, HALOPERIDOL, SULPIRIDE, PALIPERIDONE, PIMOZIDE, LURASIDONE, CLOZAPINE, AMISULPRIDE, TIAPRIDE, SERTINDOLE, CHLORPROTHIXENE | University Medical Center Groningen, ZonMw | HAMLETT compares regular treatment guidelines for patients in remission after a first episode of psychosis, namely continuation with antipsychotic medication for at least one year, with early dose reduction/discontinuation. HAMLETT vergelijkt de reguliere behandeling van patiënten in remissie na een eerste psychotische episode zoals beschreven in de richtlijnen, namelijk het continueren van antipsychotica voor minstens 1 jaar, met het vroegtijdig afbouwen/stoppen met medicatie., HAMLETT compares continuation versus early discontinuation of antipsychotic medication in patients who have recovered from their first episode of psychosis. HAMLETT vergelijkt de reguliere behandeling van patiënten die hersteld zijn van een eerste psychose, namelijk minimaal 1 jaar antipsychotica gebruiken, met vroegtijdig afbouwen/stoppn met medicatie, Psychiatry and Psychology [F] - Mental Disorders [F03] | | | | |
PSD-AOFC, NCT04876521: Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression |
|
|
| Recruiting | 4 | 60 | RoW | Amisulpride, Sulpitac, Amazeo, Soltus, Olanzapine-Fluoxetine Combination, Oleanz Fort, Oleanz Plus | All India Institute of Medical Sciences, Bhubaneswar | Post-Schizophrenic Depression | 04/22 | 05/22 | | |
NCT04446234: Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building |
|
|
| Not yet recruiting | 4 | 350 | RoW | Risperidone, Aripiprazole, Ziprasidone, Amisulpride, Quetiapine | Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine | Schizophrenia | 12/22 | 12/22 | | |
| Recruiting | 3 | 40 | | | Dr. Suresh Sundram, external | Schizophrenia and Schiaffective disorders | | | | |
NCT04528095: SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia |
|
|
| Not yet recruiting | 3 | 162 | RoW | Clozapine, Clozapine+Amisulpride, Clozapine+Gingke biloba, MECT, MST, DBS | Shanghai Mental Health Center | Treatment-resistant Schizophrenia | 12/22 | 12/22 | | |
CLOZ-AID, NCT04529226: Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis |
|
|
| Active, not recruiting | 2 | 75 | Europe | Clozapine, Nemex, Leponex, haloperidol, pimozide, olanzapine, risperidone, amisulpride | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Psychosis, Intellectual Disability | 01/25 | 12/25 | | |
| Recruiting | 2 | 180 | Europe | Cannabidiol as add-on, Placebo as add-on | Central Institute of Mental Health, Mannheim | Schizophrenia | 12/24 | 12/25 | | |
| Recruiting | 1 | 40 | | ; ; ; | Institute of Clinical Pharmacy, Central South University; Vickmans Laboratories Ltd., Hong Kong, Vickmans Laboratories Ltd.,Hong Kong | Pharmacokinetics | | | | |
NCT04533724: Study on the Gut Microbial Mechanism of Negative Symptoms of Schizophrenia |
|
|
| Not yet recruiting | 1 | 6 | NA | Amisulpride | Shanghai Mental Health Center | Negative Symptom, Schizophrenia, Amisulpride, Gut Microbiomes | 09/22 | 09/22 | | |
NCT04128683: Dopamine Receptor Contributions to Prediction Error and Reversal Learning in Anorexia Nervosa |
|
|
| Active, not recruiting | 1 | 31 | US | amisulpride, Solian, bromocriptine, Parlodel | University of California, San Diego | Anorexia Nervosa | 09/23 | 12/24 | | |
NCT05347199: Effects of a Single Dose of Amisulpride on Functional Brain Changes |
|
|
| Completed | 1 | 127 | Europe | Amisulpride Pill, Placebo | Simone Grimm, Charité Research Organisation GmbH, Boehringer Ingelheim | Major Depressive Disorder | 09/23 | 09/23 | | |
NCT06066112: Study on the Bioequivalence of Amisulpride Orally Disintegrating Tablets in Human Body |
|
|
| Recruiting | 1 | 100 | RoW | Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd., Reference (R) Amisulpride tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd. | The Affiliated Hospital of Qingdao University | Bioequivalence, Schizophrenia | 10/23 | 03/24 | | |
AMEND, NCT04789915: Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis |
|
|
| Recruiting | 1 | 46 | Europe | Memantine, Placebo | Bjorn H. Ebdrup, Lundbeck Foundation, Danish Research Centre for Magnetic Resonance, University of Copenhagen | Psychosis, Negative Symptoms With Primary Psychotic Disorder | 05/25 | 12/26 | | |
ChiCTR-INR-17012930: Effect of Peony-Glycyrrhiza Decoction to Amisulpride-induced Hyperprolactinemia in Women with Schizophrenia |
|
|
| Completed | N/A | 41 | | Peony-Glycyrrhiza Decoction; placebo | Brains Hospital of Hunan Province; Brains Hospital of Hunan Province, the National Natural Science Foundation of China | Schizophrenia | | | | |
ChiCTR-IOR-16009579: The multi-dimensional evaluation of the individualized treatment of atypical antipsychotics |
|
|
| Not yet recruiting | N/A | 800 | | Olanzapine ;Risperidone ;Aripiprazole ;Amisulpride | Shanghai Mental Health Center; Shanghai Mental Health Center, The project to promote the municipal hospital clinical skills and innovation action for three year | schizophrenia | | | | |
NCT06040944: Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients |
|
|
| Completed | N/A | 64 | RoW | antipsychotic drugs inducing hyperprolactinemia, antipsychotic drugs not inducing hyperprolactinemia | Fayoum University | Schizophrenia Spectrum and Other Psychotic Disorders, Periodontal Diseases | 10/22 | 11/22 | | |
| Not yet recruiting | N/A | | | | Beijing Anding Hospital Affiliated to Capital Medical University; Beijing Anding Hospital Affiliated to Capital Medical University, Beijing Hospitals Authority Youth Programme | schizophrenia | | | | |
NCT04218981: Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental Disorders |
|
|
| Recruiting | N/A | 200 | RoW | Antipsychotic drugs, MRI scan, Mood stabilizer, Paroxetine | Central South University | Common Mental Disorder | 06/23 | 12/23 | | |
NCT04674670: Psychobiological Mechanisms Underlying Chronic Pain |
|
|
| Completed | N/A | 48 | Europe | Bromocriptine Mesylate Capsules, Amisulpride 400 MG, Placebo, Placebo for substudy 2 | susanne becker, SNSF | Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread | 07/23 | 07/23 | | |
| Recruiting | N/A | 76 | RoW | Amisulpride, Solian, Olanzapine, Oulanning | Tianjin Anding Hospital | BPSD, Amisulpride, Olanzapine, Dementia of the Alzheimer Type | 12/23 | 05/24 | | |
PROMPT, NCT04954365: Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment |
|
|
| Withdrawn | N/A | 20000 | NA | Rescue Post-Operative Nausea and Vomiting (PONV) treatment according to the standard of care (SOC), Amisulpride | Acacia Pharma Ltd, ArborMetrix | Nausea and Vomiting, Postoperative | 12/24 | 12/24 | | |
AmisulprideTRS, NCT05956600: An Open-Label, Single-Arm Clinical Trial Evaluating the Safety and Efficacy of Amisulpride in Treating Patients With Schizophrenia and Schizoaffective Disorder Who Have Treatment-Resistant Positive Symptoms |
|
|
| Withdrawn | N/A | 20 | NA | Amisulpride 50 MG | University of California, Los Angeles, PoloMar Health LLC | Schizophrenia, Treatment-Resistant | 11/25 | 01/26 | | |